These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 7687838

  • 21. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K, Raine CS, Cross AH.
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [Abstract] [Full Text] [Related]

  • 22. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice.
    Samoilova EB, Horton JL, Chen Y.
    Cell Immunol; 1998 Nov 25; 190(1):83-9. PubMed ID: 9826450
    [Abstract] [Full Text] [Related]

  • 23. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
    Linker RA, Lühder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R.
    J Neuroimmunol; 2008 Dec 15; 205(1-2):64-72. PubMed ID: 18950871
    [Abstract] [Full Text] [Related]

  • 24. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
    McCombe PA, Nickson I, Tabi Z, Pender MP.
    J Neurol Sci; 1996 Jul 15; 139(1):1-6. PubMed ID: 8836965
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB, Schluesener HJ.
    Arch Immunol Ther Exp (Warsz); 2006 Jul 15; 54(1):51-3. PubMed ID: 16642257
    [Abstract] [Full Text] [Related]

  • 26. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats.
    Mannie MD, Dinarello CA, Paterson PY.
    J Immunol; 1987 Jun 15; 138(12):4229-35. PubMed ID: 2438337
    [Abstract] [Full Text] [Related]

  • 27. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S, Donhauser T, Toyka KV, Hartung HP.
    J Autoimmun; 1997 Dec 15; 10(6):519-29. PubMed ID: 9451591
    [Abstract] [Full Text] [Related]

  • 28. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
    Ellerman KE, Powers JM, Brostoff SW.
    Nature; 1988 Jan 21; 331(6153):265-7. PubMed ID: 2447505
    [Abstract] [Full Text] [Related]

  • 29. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H.
    Nat Med; 2003 Mar 21; 9(3):287-93. PubMed ID: 12598893
    [Abstract] [Full Text] [Related]

  • 30. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA, Blanchette BW, Russo MA, Williams AM, Colvin RB.
    J Immunol; 1987 Apr 15; 138(8):2507-13. PubMed ID: 3494072
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor.
    Constantin G, Laudanna C, Brocke S, Butcher EC.
    J Immunol; 1999 Jan 15; 162(2):1144-9. PubMed ID: 9916745
    [Abstract] [Full Text] [Related]

  • 32. Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis.
    Lohse AW, Schwerdt A, Herkel J, Spahn T, Meyer zum Büschenfelde KH.
    J Autoimmun; 1995 Jun 15; 8(3):395-404. PubMed ID: 7576000
    [Abstract] [Full Text] [Related]

  • 33. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN.
    Arch Immunol Ther Exp (Warsz); 2000 Jun 15; 48(5):381-8. PubMed ID: 11140465
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA, Kamoun M, Ventura E, Rostami A.
    Exp Mol Pathol; 2000 Feb 15; 68(1):29-37. PubMed ID: 10640452
    [Abstract] [Full Text] [Related]

  • 35. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM, Bhopale MK, Constantinescu CS, Ciric B, Hilliard B, Ventura E, Lavi E, Rostami A.
    J Neurol Sci; 2007 Dec 15; 263(1-2):59-69. PubMed ID: 17603081
    [Abstract] [Full Text] [Related]

  • 36. Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells.
    Tischner D, Weishaupt A, van den Brandt J, Ip CW, Kerkau T, Gold R, Reichardt HM.
    J Neuroimmunol; 2007 Feb 15; 183(1-2):146-50. PubMed ID: 17198735
    [Abstract] [Full Text] [Related]

  • 37. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin.
    Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G.
    J Clin Invest; 1998 Dec 15; 102(12):2096-105. PubMed ID: 9854045
    [Abstract] [Full Text] [Related]

  • 38. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
    Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE.
    J Immunol; 1991 May 01; 146(9):3012-7. PubMed ID: 1707929
    [Abstract] [Full Text] [Related]

  • 39. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
    Holoshitz J, Frenkel A, Ben-Nun A, Cohen IR.
    J Immunol; 1983 Dec 01; 131(6):2810-3. PubMed ID: 6196400
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.